OneSource Specialty (ONESOURCE) | Stock Overview & Key Data
OneSource Specialty Performance Comparison
Stock Range
Today's Range
Low: ₹1,860.00
High: ₹1,901.00
on August 8, 2025
52 Week Range
Low: ₹1,209.95
High: ₹2,248.00
on March 3, 2025
on June 18, 2025
All-Time High: ₹2,248.00 on June 18, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR217.1B
EPS
-1.53
P/E Ratio (TTM)
-1,151.72
Forward P/E
28.79
P/B Ratio
3.69
PEG Ratio
11.72
Div. Yield
N/A
ROE
-0.31%
Beta
N/A
Debt to Equity
16.03
Financial Highlights
Profitability
Gross Margin
71.61%
Operating Margin
6.32%
Profit Margin
-0.85%
Returns and Earnings
Return on Assets (TTM)
-0.24%
Return on Equity (TTM)
-0.31%
EBITDA
INR4.8B
Net Income (TTM)
INR-119.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR129.32
Quarterly Revenue Growth (YoY)
317.50%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| OneSource Specialty ONESOURCE | 217.07B Large-cap | 1.94% | -5.48% | 18.19% | 22.64% | 10.61% | 10.61% | 10.61% | 10.61% |
| Biocon BIOCON | 486.32B Large-cap | -10.79% | -7.47% | 2.14% | -9.39% | -7.33% | 8.09% | 17.05% | -7.82% |
| Concord Biotech CONCORDBIO | 170.64B Mid-cap | -8.20% | -10.88% | 4.92% | -28.51% | -25.63% | 2.85% | 69.50% | 69.50% |
| Blue Jet Healthcare BLUEJET | 136.36B Mid-cap | 1.11% | -8.20% | 11.31% | -0.69% | 39.42% | 63.78% | 99.82% | 99.82% |
| Supriya Lifescience SUPRIYA | 53.24B Mid-cap | 0.14% | -6.62% | 3.08% | -9.09% | -13.05% | 46.20% | 85.49% | 35.98% |
| Dishman Carbogen DCAL | 37.57B Small-cap | -3.47% | -8.84% | 27.79% | -2.26% | -17.23% | 22.14% | 106.15% | 27.13% |
Ownership & Short Interest
Insider Ownership
40.52%
Institutional Ownership
24.07%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
178K
Average 90-Day Volume
200K
OneSource Specialty Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in OneSource Specialty would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ONESOURCE's 52-week high and low?
- In the last 52 weeks, OneSource Specialty reached a high of ₹2,248.00 (on June 18, 2025) and a low of ₹1,209.95 (on March 3, 2025).
- What is the market cap and P/E ratio for ONESOURCE?
- Curious about OneSource Specialty's size and valuation? Its market capitalization stands at 217.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is -1,151.72, and the forward P/E (looking ahead) is 28.79.
- Does ONESOURCE pay dividends? If so, what's the yield?
- As for dividends, OneSource Specialty isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are OneSource Specialty's main competitors or similar companies to consider before investing?
When looking at OneSource Specialty, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON486.32B Healthcare Biotechnology 8.09% 17.05% Concord Biotech
CONCORDBIO170.64B Healthcare Biotechnology 2.85% 69.50% Blue Jet Healthcare
BLUEJET136.36B Healthcare Biotechnology 63.78% 99.82% Supriya Lifescience
SUPRIYA53.24B Healthcare Biotechnology 46.20% 85.49% Dishman Carbogen
DCAL37.57B Healthcare Biotechnology 22.14% 106.15% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for OneSource Specialty Pharma Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of OneSource Specialty's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.31%, the Debt to Equity ratio from the most recent quarter is 16.03, and its Gross Profit Margin stands at 71.61%.
- What is the recent revenue and earnings growth for ONESOURCE?
- Looking at OneSource Specialty's growth, its revenue over the trailing twelve months (TTM) was INR15B. Compared to the same quarter last year (YoY), quarterly revenue grew by 317.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of ONESOURCE stock is held by insiders and institutions?
- Wondering who owns OneSource Specialty stock? Company insiders (like executives and directors) hold about 40.52% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 24.07%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.